Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$38,435,724
+$17,174,214 QoQ
Shares Held
2,583,046
+2.8% QoQ
Ownership
1.71%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 294 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Derivatives in BHVN
reported options exposure · as of Dec 31, 2025CallValue
$772,236
CallShares
68,400
PutValue
$2,060,425
PutShares
182,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. BHVN ranks #80 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in BHVN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,435,724 | 2,583,046 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $21,261,510 | 2,513,181 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,153,305 | 1,962,206 | Shares | Defined | 2026-03-25 | |
| 2025-12-31 | $772,236 | 68,400 | Call | Defined | 2026-03-25 | |
| 2025-12-31 | $2,060,425 | 182,500 | Put | Defined | 2026-03-25 | |
| 2025-09-30 | $23,691,633 | 1,578,390 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $4,346,896 | 289,600 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $750,500 | 50,000 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $13,826,628 | 979,917 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $19,326,381 | 803,926 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $30,508,338 | 816,823 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $32,099,527 | 642,376 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $25,309,108 | 729,159 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $51,432,335 | 940,434 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $40,476,601 | 945,715 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $22,729,227 | 873,865 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $18,154,705 | 758,976 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $5,675,647 | 415,494 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $10,061,362 | 724,882 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||